we are not close. LPCN was original company to submit fluticare (lpcn-1021) for ANDA approval but they were required to redo phase 3 by FDA. So now they r enrolling people in trial in first half of 2017 and results expected by the end of 2017. You can go to their website read all announcments.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.